Let's be clear, this is a total PR move. The company is trying to stay ahead of the recent article showing how we, Lilly, and Sanofi, raise the price of our insulin in lock step with one another like some cartel. I would love to see the new CEO go before congress to explain this. Ask the Mylan CEO how her day went yesterday.
This latest "olive branch" is being extended so Novo can justify the price hikes to US customers in order support this wonderful 20% to poorer nations. NNI TBL at its best - total Balogna